摘要
目的 评估B超引导下经直肠前列腺12点穿刺活检术的安全性及对前列腺癌的诊断价值。方法 统计我院自2011年6月至2014年6月行B超引导下经直肠前列腺12点穿刺活检术的患者238例。在前列腺两侧旁正中线矢状切面尖部、中部和底部各穿刺3点,左右侧外周带各2点,对超声检查发现前列腺结节及中叶穿刺1-3点。结果 在238例患者中,前列腺癌患者82例（34.45%）,前列腺增生患者69例（29.00%）,前列腺增生合并慢性前列腺炎患者87例（36.55%）。其中72例患者出现肉眼血尿（30.25%）、血便21例（8.88%）、急性尿潴留35例（14.70%）、发热14例（4.34%）、脓毒症4例（1.68%）,无其他严重并发症。结论 B超引导下经直肠前列腺12点穿刺活检术对前列腺癌的检出率高、操作简便、患者痛苦小、并发症少,是临床诊断前列腺癌的一种快速、安全、有效的诊断方法,具有较好的临床应用价值。
Objective To explore the safety and clinical value of B ultrasound guided transrectal 12 cores prostate biopsy for diagnosing prostate carcinoma. Methods From June 2011 to June 2014, 495 patients who received transrectal ultrasound guided 12 cores prostate biopsy were analyzed retrospectively. Three points at each of the right and left lobe, and 2 points at the midlobar were punctured. If a hypoechoic area was identified, 1-3 points were taken from this area and the midlobar. Results Prostate carcinoma were detected in 82 patients （34.45%）, benign prostatic hyperplasia 69 cases（29.00%）, prostatitis 87 cases（36.55%）. 72 patients had gross hematuria（30.25%）, 21 patients had hematochezia（8.88%）, 14 patients got fever（4.34%） and 4 patients had sepsis. There were no other severe complications occurred. Conclusions B ultrasound guided transrectal 12 cores prostate biopsy is a effective and safe method for diagnosing prostate carcinoma. It should be considered the first choice to diagnose prostate carcinoma.
出处
《中国医药指南》
2014年第23期1-1,3,共2页
Guide of China Medicine
基金
广东省卫生厅科学技术研究基金(编号:A2012726)
关键词
前列腺癌
穿刺术
组织活检
超声
经直肠
Prostate cancer
Puncture
Tissue biopsy
Ultrasound
Transrectal
